PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2014 Sustainabilty Report

22 Apr 2015 16:28

RNS Number : 0427L
Reckitt Benckiser Group PLC
22 April 2015
 



 

PRESS RELEASE

 

RB announces progress towards environmental and social goals in 2014 Sustainability Report

London, UK, April 22, 2015 - RB's 2014 Sustainability Report, "A global force in health & hygiene", published today, highlights the key achievements of its betterbusiness strategy. By end 2014:

 

· Over 141 million people reached with health and hygiene messaging, 70% of goal to reach 200 million people by 2020

· 50% of products in pipeline more sustainable than their predecessors 

· 74% of factories sending zero waste to landfill, including hazardous and non-hazardous waste

· 25% reduction in water use per unit of production

 

RB, the global leader in consumer health and hygiene, reveals that it has reached over 141 million people since 2013 with health and hygiene messaging. RB has achieved 70% of its 2020 goal to reach over 200 million people to improve their health and hygiene through programmes led by brands including Dettol and Durex. For example, Durex's "Someone Like Me" programme has reached approximately 70 million people with sexual health messaging while 70 million people have been reached through Dettol and Harpic's hygiene education and sanitation programmes.

 

RB has reduced the environmental footprint of the products in its pipeline by embedding sustainability into the way it innovates. RB uses a bespoke online tool that guides the development of low-impact products by showing designers the environmental impacts of their decisions in real time. RB's entire product pipeline is continually assessed by the tool. By end 2014, 50% of the pipeline consisted of innovations that are more sustainable than existing RB products. RB is one of the first businesses to take a portfolio view of its product development process through a sustainability lens and has reduced the overall carbon footprint and water impact of its products by 3% and 2% per dose, respectively, since its baseline year of 2012.

 

In manufacturing, 74% of RB factories are sending zero waste to landfill (including hazardous and non-hazardous manufacturing waste). Since 2012, RB has gone from four to 35 factories achieving zero waste to landfill and reduced water and energy use by 25% and 13% respectively (per unit of production). RB has also seen a 13% reduction in lost work day accident rates since 2012.

Rakesh Kapoor, CEO, commented:

"This report demonstrates good progress against our betterbusinees strategy which charts a course for sustainable, responsible growth. While I am proud of the progress that we have made, we will continue to challenge ourselves to do more with less to achieve our vision of a world where people are healthier and live better."

 

For further information, visit: rb.com/sustainability.

 

Note: RB's betterbusiness sustainability strategy includes three goals for 2020:

· To cut the water and carbon footprint of products by one third per dose

· To achieve one third of net revenue from more sustainable products

· To reach over 200 million people to improve their health and hygiene behavior

 

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in almost 200 countries. The company employs approximately 37,000 people worldwide.

With a purpose of delivering innovative solutions for healthier lives and happier homes, RB is in the top 20 of companies listed on the London Stock Exchange. Today it is the global No 1or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands of Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. 75% of core revenues came from the health and hygiene categories of the portfolio.

 

Fuelled by a new breed of talent who blend intellectual curiosity with commitment to the highest quality standards, RB is set to redefine the world of consumer health and hygiene. RB people and its culture are at the heart of the company's success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in sustainability where the company is targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and to have 1/3 of its net revenue coming from more sustainable products by 2020. It is also the Save the Children charity's largest FMCG global partner, with a new partnership vision to radically reduce the world's second biggest killer of under-fives, diarrhoea. Overall RB wants to reach 200 million people to improve their health and hygiene behaviour.

 

RB is listed in the Dow Jones Sustainability World Index (DJSI). The company was named leader of the Household Products industry and earned 'industry best' scores for the broad economic and environmental dimensions. RB is also a member of the CDP FTSE 350 Carbon Disclosure Leadership Index and was ranked 7th in the Corporate Knights Global 100 Most Sustainable Corporations in the World Index.

For more information visit www.rb.com

*RB is the trading name of Reckitt Benckiser group of companies.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCELLFLEZFLBBQ
Date   Source Headline
9th Apr 202010:00 amRNSDirectorate Change
6th Apr 202011:42 amRNSAnnual Financial Report
3rd Apr 202010:31 amRNSDirector Declaration
1st Apr 202011:26 amRNSTotal Voting Rights
24th Mar 20204:57 pmRNSDirector/PDMR Shareholding
24th Mar 20204:41 pmRNSSecond Price Monitoring Extn
24th Mar 20204:35 pmRNSPrice Monitoring Extension
12th Mar 20205:08 pmRNSDirector/PDMR Shareholding
9th Mar 20204:45 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:26 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:11 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSFull Year Results 2019
3rd Feb 202011:16 amRNSTotal Voting Rights
2nd Jan 202012:20 pmRNSTotal Voting Rights
4th Dec 20191:30 pmRNSDirectorate Change
2nd Dec 201912:00 pmRNSTotal Voting Rights
1st Nov 201912:00 pmRNSTotal Voting Rights
29th Oct 20194:30 pmRNSDirector/PDMR Shareholding
28th Oct 201911:21 amRNSDirector/PDMR Shareholding
24th Oct 20192:30 pmRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSQ3 2019 Trading Update
21st Oct 201910:15 amRNSDirectorate Change
1st Oct 201911:51 amRNSTotal Voting Rights
30th Sep 20193:12 pmRNSDirector/PDMR Shareholding
18th Sep 201912:00 pmRNSDirectorate Change
3rd Sep 20191:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20191:00 pmRNSDirectorate Change
2nd Sep 201912:37 pmRNSTotal Voting Rights
30th Aug 20193:00 pmRNSDirector/PDMR Shareholding
6th Aug 20192:07 pmRNSDirector/PDMR Shareholding
1st Aug 20199:48 amRNSTotal Voting Rights
30th Jul 20197:00 amRNSHalf Year Results 2019
29th Jul 20199:30 amRNSDirectorate Change
11th Jul 20197:00 amRNSAgreement to resolve all federal investigations
1st Jul 201911:31 amRNSTotal Voting Rights
12th Jun 20197:00 amRNSRB CEO Announcement
3rd Jun 201910:49 amRNSTotal Voting Rights
28th May 201910:40 amRNSDirector/PDMR Shareholding
23rd May 20194:40 pmRNSDirector/PDMR Shareholding
22nd May 201911:45 amRNSDirector/PDMR Shareholding
13th May 20193:01 pmRNSDirector/PDMR Shareholding
9th May 20193:28 pmRNSResult of AGM
2nd May 20197:00 amRNSQ1 Trading Update
1st May 201910:46 amRNSDirectorate Change
1st May 20199:00 amRNSTotal Voting Rights
10th Apr 201910:37 amRNSUS Justice Department indictment of Indivior Plc
4th Apr 201912:45 pmRNSDirector Declaration
2nd Apr 20194:56 pmRNSAnnual Financial Report
1st Apr 20199:30 amRNSTotal Voting Rights
27th Mar 20192:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.